OBIO同业对比
OBIO 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OBIO本股 | $362M#7 | — | 3.6x#6 | 10.8x#12 | 1169.2%#1 | 13.6%#8 | -154.7%#12 | -52.8%#8 | -54.9%#8 | — | — | 5.5%#2 |
| NPCE | $483M#1 | — | 40.6x#12 | 4.8x#7 | 25.1%#4 | 20.9%#7 | -16.3%#5 | -180.6%#10 | -28.0%#6 | 4#6 | — | — |
| PMI | $15M#14 | — | 8.6x#10 | 3.0x#6 | 12.5%#6 | -28.2%#10 | -268.4%#13 | -1573.5%#12 | -495.0%#12 | — | -98.3%#6 | — |
| SGHT | $448M#2 | — | 8.5x#9 | 5.8x#8 | -3.1%#10 | 25.4%#5 | -48.0%#7 | -72.6%#9 | -266.6%#11 | 5#3 | 133.9%#2 | — |
| CARL | $421M#3 | 140.3x#4 | 5.0x#8 | 8.3x#10 | 85.9%#2 | -22.2%#9 | -60.5%#9 | -35.2%#7 | -57.3%#9 | 5#3 | 0.6%#4 | — |
| CLPT | $409M#4 | — | 37.9x#11 | 11.1x#13 | 17.8%#5 | -35.0%#11 | -65.4%#11 | -237.0%#11 | — | — | — | — |
| SI | $373M#5 | 0.1x#1 | 3.0x#5 | 7.9x#9 | 49.6%#3 | -158.4%#12 | -55.6%#8 | -32.5%#6 | -22.9%#5 | 3#9 | 14.7%#3 | — |
| OFIX | $363M#6 | — | 0.8x#2 | 0.4x#2 | 2.9%#9 | 26.8%#4 | -9.9%#4 | -21.5%#4 | -14.9%#4 | 5#3 | -39.9%#5 | — |
| CTSO | $360M#8 | — | — | 9.7x#11 | 4.1%#8 | 60.4%#3 | -39.8%#6 | — | -122.1%#10 | 4#6 | — | — |
| MOBI | $359M#9 | — | 2.1x#4 | — | — | — | — | 0.0%#2 | — | — | — | — |
| EMBC | $291M#10 | 3.5x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#6 | 22.4%#1 | — | 27.0%#1 | 6#2 | — | 12.0%#1 |
| ANIK | $279M#11 | — | 2.0x#3 | 2.5x#5 | -5.9%#12 | 80.4%#2 | -9.8%#3 | -8.0%#3 | -8.8%#3 | 4#6 | 141.0%#1 | — |
| INFU | $248M#12 | 31.2x#3 | 4.2x#7 | 1.7x#3 | 6.4%#7 | 182.6%#1 | 8.3%#2 | 11.2%#1 | 9.5%#2 | 9#1 | — | — |
| OSUR | $241M#13 | — | 0.8x#1 | 2.1x#4 | -38.1%#13 | -252.5%#13 | -62.6%#10 | -21.6%#5 | -43.8%#7 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议